echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hengqin has issued special policies to support the development of the biomedical health industry

    Hengqin has issued special policies to support the development of the biomedical health industry

    • Last Update: 2022-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The Measures of the Guangdong-Macao Intensive Cooperation Zone in Hengqin to Support the High-quality Development of the Biomedical Health Industry (hereinafter referred to as the "Several Measures") were officially launched
    on 31 October.
    The "Several Measures" focus on supporting the landing of high-quality Australian-funded projects, and provide support for Australian-funded projects that meet the requirements by 20% on the basis of the calculation results of the subsidy standard for non-Australian-funded projects
    .
     
    It is understood that as the first special support measure to support the development of the biomedical and health industry since the establishment of the Guangdong-Macao Intensive Cooperation Zone in Hengqin, the "Several Measures" lists five chapters of specific support measures, adhering to the main purpose of serving Macao's industrial diversification and driving R&D and innovation, through precise support for key projects and benchmarking projects including Macao projects, launching the brand of "Macao registration + Hengqin production", strengthening R&D and innovation support, and optimizing the industrial development ecology.
    Create a full life cycle support environment for biomedical and health enterprises in the cooperation zone, and achieve full coverage
    from landing to industrialization.
     
    Among them, the "Several Measures" give key support
    to Macao-related projects.
    Focus on supporting the landing of high-quality Australian-funded projects, and increase the subsidy standard for non-Australian-funded projects by 20% on the basis of the calculation results of the subsidy standard for non-Australian-funded projects that meet the requirements; At the same time, riding on the east wind of Macao's newly promulgated Law on Chinese Medicine Pharmaceutical Activities and Registration of Proprietary Chinese Medicines, Hengqin is encouraged to develop proprietary Chinese medicine products for registration in Macao, and the award standard will be increased by 20%
    based on the calculation results of non-Macao-funded projects according to the progress of product research and development and the actual investment in R&D expenses.
     
    At the same time, for Chinese medicine products, food and health products approved and registered in Macao and produced in the ETCZs, and allowed to use the "Macao supervised", "Macao supervised" or "Macao designed" logos, the relevant subsidies for each variety can reach up to 20 million yuan (RMB, the same below).

    At the same time, enterprises in the ETCZs are encouraged to apply for relevant production licenses and undertake the landing production
    of Macao-registered products.
     
    Support the development of industry-university-research demonstration bases for Macao universities in the ETCZs, with an annual subsidy of up to RMB 5 million per base
    .
    For projects in the field of biomedicine and health that receive science and technology funding from the Macao SAR Government, a matching subsidy
    of up to 8 million yuan will be given to a single project.
     
    In addition, to promote the internationalization of "Macao Registration + Hengqin Production", while encouraging international registration, we will simultaneously support and encourage the introduction of imported new drugs, strengthen quality standardization management, and further enhance the internationalization level of the biomedical and health industry in the Cooperation Zone, with a cumulative total of up to 36 million yuan
    .
    (End)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.